טוען...
Targeted therapies in the treatment of adult acute myeloid leukemias: current status and future perspectives
The rapid advancement of next-generation sequencing techniques and the identification of molecular driver events responsible for leukemia development are opening the door to new pharmacologic-targeted agents to tailor treatment of acute myeloid leukemia (AML) in individual patients. However, the use...
שמור ב:
| הוצא לאור ב: | Int J Hematol Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Medicine Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172000/ https://ncbi.nlm.nih.gov/pubmed/30302215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2016-0011 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|